Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000251079 | SCV000317290 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Center for Pediatric Genomic Medicine, |
RCV000429535 | SCV000511074 | likely benign | not provided | 2016-09-12 | criteria provided, single submitter | clinical testing | Converted during submission to Likely benign. |
Gene |
RCV000251079 | SCV000533369 | benign | not specified | 2018-02-12 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Athena Diagnostics | RCV000251079 | SCV000612358 | likely benign | not specified | 2016-03-03 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001083310 | SCV000645907 | benign | Gnathodiaphyseal dysplasia; Autosomal recessive limb-girdle muscular dystrophy type 2L | 2025-01-23 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002259753 | SCV002539232 | benign | Gnathodiaphyseal dysplasia | 2021-12-05 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002259755 | SCV002539233 | benign | Miyoshi muscular dystrophy 3 | 2021-12-05 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002259754 | SCV002539234 | benign | Autosomal recessive limb-girdle muscular dystrophy type 2L | 2021-12-05 | criteria provided, single submitter | clinical testing |